The early promise of an anti-obesity drug may never be fulfilled following the discontinuation of a randomized trial for safety reasons and a subsequent data analysis showing no evidence of efficacy for the study's primary endpoint of reduced cardiovascular risk.Give yourself a chance to shed the weight naturally, effectively and properly.
Fitness Watch is your site for making sense of fitness advice.
"Truth" has a shelf life.
The shelf life of "truth" is very short in the domains of fitness, health and well-being.
The reason is that so much of what we are told is "true" is really baseless.
At Fitness Watch we separate fitness information from fitness noise.
Saturday, August 28, 2010
No Cardiovascular Benefit Found for Rimonabant
More IMHO malpractice re: diet drugs.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.